Advertisement
Home 2016 June

Monthly Archives: June 2016

During a presentation at the 2016 American Medical Association Annual Meeting

Tips Provided for Leveraging Social Media

0
Kevin Pho of KevinMD shares insights into social media use in health care
Cognitive-training programs like Lumosity or NeuroNation may be offering only placebo effects

Placebo Effect Seen in Brain-Training Program Effectiveness

0
Researchers need to account for placebo effects before claiming treatment success
Very low target low-density lipoprotein cholesterol levels may not benefit all patients with preexisting heart disease

Moderately Low LDL May Be Enough to Ward Off CVD Risk

0
Researchers find reduction to 70 mg/dL range not associated with additional benefit
Obstructive sleep apnea may be associated with cognitive dysfunction in patients with multiple sclerosis

Sleep Apnea Could Worsen Cognitive Deficits in MS Patients

0
Link found between severity of sleep apnea and performance on attention, memory tests
More than one-third of U.S. patients with atrial fibrillation who need anticoagulation to prevent strokes aren't receiving it

Too Many A-Fib Patients Taking Aspirin Instead of Anticoagulant

0
Anticoagulants -- not aspirin -- dramatically cut the risk of stroke, researchers say
The risk of type 1 diabetes remains elevated for children who have developed multiple β-cell autoantibodies

Risk of T1DM Up in Children With Autoantibody Reversion

0
Risk of type 1 diabetes up for children who reverted from single autoantibody to autoantibody negative
For patients with prediabetes or type 2 diabetes mellitus and nonalcoholic steatohepatitis

Long-Term Pioglitazone Safe, Effective for NASH, T2DM

0
Safe and effective for patients with prediabetes or type 2 diabetes and nonalcoholic steatohepatitis
Almost half of older Medicare beneficiaries have high persistent spending throughout the full year before death

Persistent High Spending Common in Year Before Death

0
Overall, 48.7 percent of older Medicare beneficiaries who died in 2012 had persistent high spending
For patients with heart failure due to light-chain amyloidosis

Three-Drug Tx Ups Survival in Light-Chain Amyloidosis

0
Bortezomib, dexamethasone, alkylating agent treatment ups survival for patients with heart failure
For subjects without obesity

Striatal D2 Receptors, Age Linked to Sucrose Preference

0
In subjects without obesity, striatal D2R binding potential, age linked to sucrose preference